- Home
- RCKT vs TCMD Comparison
RCKT vs TCMD Comparison
Compare RCKT & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- TCMD
- Stock Information
- Founded
- RCKT 1999
- TCMD 1995
- Country
- RCKT United States
- TCMD United States
- Employees
- RCKT N/A
- TCMD N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- TCMD Medical/Dental Instruments
- Sector
- RCKT Health Care
- TCMD Health Care
- Exchange
- RCKT Nasdaq
- TCMD Nasdaq
- Market Cap
- RCKT 328.6M
- TCMD 288.7M
- IPO Year
- RCKT N/A
- TCMD 2016
- Fundamental
- Price
- RCKT $3.28
- TCMD $13.46
- Analyst Decision
- RCKT Buy
- TCMD Hold
- Analyst Count
- RCKT 13
- TCMD 3
- Target Price
- RCKT $12.96
- TCMD $13.50
- AVG Volume (30 Days)
- RCKT 5.9M
- TCMD 206.3K
- Earning Date
- RCKT 11-06-2025
- TCMD 11-03-2025
- Dividend Yield
- RCKT N/A
- TCMD N/A
- EPS Growth
- RCKT N/A
- TCMD N/A
- EPS
- RCKT N/A
- TCMD 0.63
- Revenue
- RCKT N/A
- TCMD $298,851,000.00
- Revenue This Year
- RCKT N/A
- TCMD $8.85
- Revenue Next Year
- RCKT $108.43
- TCMD $8.24
- P/E Ratio
- RCKT N/A
- TCMD $21.53
- Revenue Growth
- RCKT N/A
- TCMD 6.15
- 52 Week Low
- RCKT $2.19
- TCMD $8.61
- 52 Week High
- RCKT $22.01
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- RCKT 51.09
- TCMD 66.75
- Support Level
- RCKT $3.16
- TCMD $12.91
- Resistance Level
- RCKT $3.40
- TCMD $13.64
- Average True Range (ATR)
- RCKT 0.27
- TCMD 0.36
- MACD
- RCKT -0.01
- TCMD -0.03
- Stochastic Oscillator
- RCKT 32.79
- TCMD 87.05
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.